Caligan Partners LP Diversified Active

CIK: 0001727492 · Show all filings

Period: Q3 2025 (← Previous) (Next →)

Filing Date: Nov 14, 2025

Total Value ($000): $763,509 (100.0% shares, 0.0% debt)

Holdings (18)

LQDA LIQUIDIA CORPORATION 24.2%

Value ($000) $184,624 Shares 8,118,892 Est. Cost $5.57 Unrealized +289.4%

ABVX ABIVAX SA 16.1%

Value ($000) $123,268 Shares 1,451,924 Est. Cost $7.07 Unrealized —

MLYS MINERALYS THERAPEUTICS INC 13.8%

Value ($000) $105,139 Shares 2,772,654 Est. Cost $14.60 Unrealized +48.1%

EXEL EXELIXIS INC 8.3%

Value ($000) $63,013 Shares 1,525,730 Est. Cost $19.42 Unrealized +107.0%

RVMD REVOLUTION MEDICINES INC 6.5%

Value ($000) $49,700 Shares 1,064,249 Est. Cost $39.66 Unrealized -1.3%

AGIO AGIOS PHARMACEUTICALS INC 5.9%

Value ($000) $45,407 Shares 1,131,205 Est. Cost $29.40 Unrealized +27.9%

AGIO AGIOS PHARMACEUTICALS INC 5.1%

Value ($000) $39,137 Shares 975,000 Est. Cost $29.40 Unrealized +27.9%

ADMA ADMA BIOLOGICS INC 5.1%

Value ($000) $38,653 Shares 2,636,609 Est. Cost $17.14 Unrealized 0.0%

EOLS EVOLUS INC 3.3%

Value ($000) $25,413 Shares 4,138,943 Est. Cost $10.04 Unrealized -22.3%

— MERUS N V 2.7%

Value ($000) $20,426 Shares 216,954 Est. Cost $46.55 Unrealized —

XENE XENON PHARMACEUTICALS INC 2.3%

Value ($000) $17,849 Shares 444,565 Est. Cost $35.22 Unrealized 0.0%

ANIK ANIKA THERAPEUTICS INC 1.8%

Value ($000) $13,490 Shares 1,435,130 Est. Cost $25.57 Unrealized -62.7%

AVTX AVALO THERAPEUTICS INC 1.4%

Value ($000) $10,592 Shares 833,333 Est. Cost $8.60 Unrealized 0.0%

TYRA TYRA BIOSCIENCES INC 1.3%

Value ($000) $9,749 Shares 696,825 Est. Cost $11.01 Unrealized +3.6%

INBX INHIBRX BIOSCIENCES INC 1.0%

Value ($000) $7,961 Shares 236,383 Est. Cost $24.62 Unrealized 0.0%

VRCA VERRICA PHARMACEUTICALS INC 0.5%

Value ($000) $3,982 Shares 923,910 Est. Cost $6.03 Unrealized 0.0%

SLS SELLAS LIFE SCIENCES GROUP I 0.5%

Value ($000) $3,703 Shares 2,300,000 Est. Cost — Unrealized —

AURA AURA BIOSCIENCES INC 0.2%

Value ($000) $1,404 Shares 227,174 Est. Cost $5.93 Unrealized +10.3%

Ticker	Issuer	Shares	Value ($000)	%	Est. Cost	Unrealized	Class	CUSIP
LQDA	LIQUIDIA CORPORATION	8,118,892	$184,624	24.2%	$5.57	+289.4%	COM NEW	53635D202
ABVX	ABIVAX SA	1,451,924	$123,268	16.1%	$7.07	—	SPONSORED ADS	00370M103
MLYS	MINERALYS THERAPEUTICS INC	2,772,654	$105,139	13.8%	$14.60	+48.1%	COM	603170101
EXEL	EXELIXIS INC	1,525,730	$63,013	8.3%	$19.42	+107.0%	COM	30161Q104
RVMD	REVOLUTION MEDICINES INC	1,064,249	$49,700	6.5%	$39.66	-1.3%	COM	76155X100
AGIO	AGIOS PHARMACEUTICALS INC	1,131,205	$45,407	5.9%	$29.40	+27.9%	COM	00847X104
AGIO	AGIOS PHARMACEUTICALS INC	975,000	$39,137	5.1%	$29.40	+27.9%	Put	00847X104
ADMA	ADMA BIOLOGICS INC	2,636,609	$38,653	5.1%	$17.14	0.0%	COM	000899104
EOLS	EVOLUS INC	4,138,943	$25,413	3.3%	$10.04	-22.3%	COM	30052C107
—	MERUS N V	216,954	$20,426	2.7%	$46.55	—	COM	N5749R100
XENE	XENON PHARMACEUTICALS INC	444,565	$17,849	2.3%	$35.22	0.0%	COM	98420N105
ANIK	ANIKA THERAPEUTICS INC	1,435,130	$13,490	1.8%	$25.57	-62.7%	COM	035255108
AVTX	AVALO THERAPEUTICS INC	833,333	$10,592	1.4%	$8.60	0.0%	COM NEW	05338F306
TYRA	TYRA BIOSCIENCES INC	696,825	$9,749	1.3%	$11.01	+3.6%	COM	90240B106
INBX	INHIBRX BIOSCIENCES INC	236,383	$7,961	1.0%	$24.62	0.0%	COM	45720N103
VRCA	VERRICA PHARMACEUTICALS INC	923,910	$3,982	0.5%	$6.03	0.0%	COM SHS	92511W207
SLS	SELLAS LIFE SCIENCES GROUP I	2,300,000	$3,703	0.5%	—	—	Call	81642T209
AURA	AURA BIOSCIENCES INC	227,174	$1,404	0.2%	$5.93	+10.3%	COM	05153U107